A clinical trial to study the effect of Pankajakasthuri Breath Eazy Mishrit, in patients with cough, cold and breathing difficulties.
- Conditions
- Health Condition 1: J454- Moderate persistent asthmaHealth Condition 2: J454- Moderate persistent asthmaHealth Condition 3: null- The Patients with Bronchial Asthma visiting PANKAJAKASTHURI AYURVEDA MEDICAL COLLEGE OUT PATIENT DEPARATMENTS for consultation.
- Registration Number
- CTRI/2016/10/007389
- Lead Sponsor
- Pankajakasthuri Ayurveda Medical College and Post Graduate Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Both sex with equal distributor with or without rhinitis.
3 Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.
Asthmatic meet reversibility criteria (15% improvement in FEVI after Beta â?? 2 agonist inhalation)
5
Mild intermittent, moderate persistent, severe persistent to severe Asthma (As per WHO GINA guidlines of duration more than 6 months)
Dyspnoea due to other disease like Left ventricular failure, COPD (Chronic Bronchitis, Emphysema), Upper respiratory tract obstruction, Bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational Lung disease, tropical pulmonary eosinophilia, Lofflers disease & Allergic Bronchopulmonary Aspergillosis etc.
Diabetes Mellitus and Hypertension.
Severe renal/Hepatic disease
HIV positive cases
Lung Cancer
Pregnant/lactating mother
Patient who need Salbutamol inhaler daily.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method More than 70% of participants had 100% releif Percentage calculation and assessment criteria based on scoring of grading by using the following parameters. <br/ ><br>Frequency of swasa vega (Difficulty in respiration) <br/ ><br>2Intensity and duration of attack <br/ ><br>3Swasa krichrata (Dyspnoea) <br/ ><br>4Ghurghurakam (Wheezing) <br/ ><br>5Kaphashteevanam(Production of cough)Timepoint: SPECIFIC TIME FOR ASSESSING PRIMARY OUTCOME : 6 MONTHS
- Secondary Outcome Measures
Name Time Method More than 70% of participants had 100% releif Percentage calculation and assessment criteria based on scoring of grading by using the following parameters. <br/ ><br>Frequency of swasa vega (Difficulty in respiration) <br/ ><br>2Intensity and duration of attack <br/ ><br>3Swasa krichrata (Dyspnoea) <br/ ><br>4Ghurghurakam (Wheezing) <br/ ><br>5Kaphashteevanam(Production of cough)Timepoint: SPECIFIC TIME FOR ASSESSING SECONDARY OUTCOME : 60 DAYS AND 90 DAYS